| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-07 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-06 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.47 | 0.002 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.14 | 0.002 |